Historical record - last NADAC publication: 4/17/2024
Product Information
ROPINIROLE HCL 2 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0562 per EA under NDC 16729023501. Its NADAC has been published 288 times since Nov 14, 2018.
Strength
2 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729023501
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/17/2024
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204022On Market Since
10/17/2018
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 2 MG TABLET has been published 288 times since Nov 14, 2018, and over the history we have for it it has declined 13.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0562 per EA |
|---|---|
| All-time high | $0.0726 (Dec 16, 2020) |
| All-time low | $0.0562 (Apr 17, 2024) |
| Median price | $0.0655 |
| Average price | $0.0656 |
| Largest weekly change | -17.4% (Apr 17, 2024) |
| Weeks tracked | 288 |
| Tracking since | Nov 14, 2018 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 2 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0562 per EA (NDC 16729023501), effective May 15, 2024.
How has the price of ROPINIROLE HCL 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 2 MG TABLET has declined 13.1%. It has been tracked across 288 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 2 MG TABLET?
Since Nov 14, 2018, the NADAC for ROPINIROLE HCL 2 MG TABLET has ranged from a low of $0.0562 (Apr 17, 2024) to a high of $0.0726 (Dec 16, 2020), with a median of $0.0655 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 2 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ROPINIROLE HCL 2 MG TABLET, but none are currently priced below it.
Who manufactures ROPINIROLE HCL 2 MG TABLET?
ROPINIROLE HCL 2 MG TABLET (NDC 16729023501) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification